SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2532VPHM keeps climbing (quite the 3 year chart). IJ, are we going to get our CVR pasjemmeri-2/14/2012
2531Increase of sales guidance (or at least new guidance - I thought they were not pRocky9-1/5/2012
2530 ViroPharma purchases exclusive option to acquire Meritage Pharma 6:00 PM ET 12/sjemmeri-12/23/2011
2529Sorry for the confusion I caused. Fred understood. I was tracking the cumulatiIRWIN JAMES FRANKEL-10/29/2011
2528Aha! Now I get it. Best, L.Lance Bredvold-10/28/2011
2527"IJ must be sleeping in after celebrating the ballgame last nite" Thatidos-10/28/2011
2526IJ must be sleeping in after celebrating the ballgame last nite. He's referrfred hayes310/28/2011
2525No way the launch in Germany have that large an effect and I don't see how idos-10/28/2011
2524That's a surprising conclusion to me. Sales of Cinryze increased from $49.Lance Bredvold110/28/2011
2523By my calculation, Cinryze sales should cross $600M in 1Q2012. ijIRWIN JAMES FRANKEL-10/27/2011
2522ViroPharma Incorporated Reports Third Quarter 2011 Financial Results- Quarter HiIRWIN JAMES FRANKEL-10/27/2011
2521<i>tell me that you care.......</i> Antiviral Res. 2011 Sep 1. [Epscaram(o)uche-9/13/2011
2520Hospital Acquired Infections Costly, Preventable By Emily P. Walker, Washington rkrw-8/25/2011
2519ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Hutnsaf-5/12/2011
2518<i> Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing andSteve Lokness-1/24/2011
2517Since there is no OPTR thread; Note bolding <i>Optimer Pharmaceuticals ReSteve Lokness-1/4/2011
2516<i>VPHM's continued to be strong lately though not much news.</i>Steve Lokness-12/20/2010
2515VPHM's continued to be strong lately though not much news.sjemmeri-12/20/2010
25143 year high: ViroPharma Incorporated Reports Third Quarter 2010 Financial Resulsjemmeri-10/27/2010
2513PR re Cinryze industrial process delayed by FDA. Common down 8% ViroPharma ReceLance Bredvold-10/22/2010
2512Sounds gross but the data is remarkably strong. ACG: Fighting C. Diff With Fecrkrw-10/20/2010
2511ViroPharma initiated with a Buy at Caris & Company 9:19 AM ET 9/17/10 | Brisjemmeri-9/20/2010
2510NEJM published studies of Kalbitor and Firazyr medpagetoday.comidos-8/6/2010
2509Notable Calls with color from analysts who attended R&D and came away positituck-3/22/2010
2508VPHM earnings; * Q4 net sales $87.8 mln vs est $82.5 mln * Raises Cinryze saleSteve Lokness-2/24/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News